Lexaria Bioscience Corp. (LEXXW)
LEXXW Stock Price Chart
Explore Lexaria Bioscience Corp. interactive price chart. Choose custom timeframes to analyze LEXXW price movements and trends.
LEXXW Company Profile
Discover essential business fundamentals and corporate details for Lexaria Bioscience Corp. (LEXXW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
7.00
Website
https://lexariabioscience.comCEO
Richard C. Christopher
Description
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
LEXXW Financial Timeline
Browse a chronological timeline of Lexaria Bioscience Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Jul 2025
EPS came in at -$0.21 falling short of the estimated -$0.15 by -42.81%, while revenue for the quarter reached $174.00K , beating expectations by +27.01%.
Earnings released on 30 Nov 2023
EPS came in at -$0.13 , while revenue for the quarter reached $151.28K .
Earnings released on 31 Aug 2023
EPS came in at -$0.25 , while revenue for the quarter reached $226.21K .
Earnings released on 31 May 2023
EPS came in at -$0.37 , while revenue for the quarter reached $93.15K .
Earnings released on 28 Feb 2023
EPS came in at -$0.37 , while revenue for the quarter reached $93.15K .
Earnings released on 30 Nov 2022
EPS came in at -$0.22 , while revenue for the quarter reached $35.02K .
Earnings released on 31 Aug 2022
EPS came in at -$0.30 , while revenue for the quarter reached $101.48K .
Earnings released on 31 May 2022
EPS came in at -$0.40 , while revenue for the quarter reached $99.72K .
Earnings released on 28 Feb 2021
EPS came in at $0.00 , while revenue for the quarter reached $192.01K .
LEXXW Stock Performance
Access detailed LEXXW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.